Skip to main content

Shares of

Cephalon

(CEPH)

were up 1.5% to $57.93 after investment bank Morgan Stanley initiated coverage of the stock.

Women's health care company

Novavax

(NVAX) - Get Novavax, Inc. Report

rose after the company named Jeffrey Church its new chief financial officer. Church was most recently CFO at GenVec. Novavax shares were up 4.8% to $3.27.

Genitope's

(GTOP)

shares sank 4.3% to $2.46 after the company discussed interim data on its MyVax personalized immunotherapy for previously untreated follicular lymphoma. According to a regulatory filing and a conference call, as of June 15, more than half of the patients in a late-phase MyVax clinical trial, or 158 of 287 patients, got worse.

Among other health stocks on the move were

Micromet

(MITI)

, down 6.3% to $2.53,

Illumina

Scroll to Continue

TheStreet Recommends

(ILMN) - Get Illumina, Inc. Report

, falling 2.9% to $31.95,

Valera Pharmaceuticals

(VLRX) - Get Valeritas Holdings, Inc. Report

, 6.7% lower to $5.99,

Tapestry Pharmaceuticals

(TPPH)

, down 3.2% to $2.73, and

GlaxoSmithKline

(GSK) - Get GlaxoSmithKline Plc Report

, whose shares fell 1.1% to $55.02.

ImClone Systems

(IMCL)

gained 2.9% to $29.83,

Affymetrix

(AFFX)

was up 5.1% to $22.06,

Amgen

(AMGN) - Get Amgen Inc. Report

rose 0.8% to $67.12,

Dendreon

(DNDN)

advanced 2.6% to $4.38 and

Pharmion

(PHRM)

was up 7.9% to $18.09.